Learn more at LeadIQ.com

Insights

Growing Market Presence GRAIL is experiencing rapid revenue growth with Q3 Galleri revenue increasing by 28% year-over-year and test sales rising 39%, indicating strong market demand for early cancer detection solutions.

Investment Backing Supported by over 5.7 billion dollars in funding, GRAIL has substantial resources to expand commercial operations and clinical validation efforts, creating opportunities for partnerships and product adoption.

Pipeline Expansion With an anticipated FDA submission for the Galleri test and ongoing clinical studies like PATHFINDER 2, GRAIL is positioning itself for broad market penetration and reimbursement negotiations, opening avenues for sales collaboration.

Industry Alliances Collaborations and investor support from major pharmaceutical and healthcare companies suggest potential for strategic alliances that can accelerate distribution channels and co-development initiatives.

Market Trends The rising investor interest and media coverage indicate strong market momentum for multi-cancer screening technologies, presenting sales opportunities to engage healthcare providers and payers interested in cutting-edge diagnostics.

Similar companies to GRAIL

GRAIL Tech Stack

GRAIL uses 8 technology products and services including Linkedin Insight Tag, Craft CMS, Monica, and more. Explore GRAIL's tech stack below.

Linkedin Insight Tag
Analytics
Craft CMS
Content Management System
Monica
Generative Ai
PagerDuty
IT Infrastructure Monitoring
Qualtrics
Online Form Builders
Boomi
Platform As A Service
LinkedIn Sales Navigator
Sales Enablement
Denodo
Tag Management

Media & News

GRAIL's Email Address Formats

GRAIL uses at least 1 format(s):

GRAIL Email Formats	Example	Percentage
FLast@grail.com	JDoe@grail.com	85%
FirstLast@grail.com	JohnDoe@grail.com	8%
FiLast@grail.com	JoDoe@grail.com	6%
First.Last@grail.com	John.Doe@grail.com	1%

Frequently Asked Questions

Where is GRAIL's headquarters located?

GRAIL's main headquarters is located at 1525 O'Brien Drive Menlo Park, CA 94025 US. The company has employees across 5 continents, including North AmericaEuropeAsia.

What is GRAIL's phone number?

You can contact GRAIL's main corporate office by phone at

+1-650-454-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is GRAIL's stock symbol?

GRAIL is a publicly traded company; the company's stock symbol is GRAL.

What is GRAIL's official website and social media links?

GRAIL's official website is grail.com and has social profiles on LinkedIn.

What is GRAIL's SIC code NAICS code?

GRAIL's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does GRAIL have currently?

As of October 2025, GRAIL has approximately 1.1K employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: B. R.Chief Executive Officer And Founder: R. M.Chief Of Staff To The President, Head Of Strategy & Operations: Z. R.. Explore GRAIL's employee directory with LeadIQ.

What industry does GRAIL belong to?

GRAIL operates in the Biotechnology Research industry.

What technology does GRAIL use?

GRAIL's tech stack includes Linkedin Insight TagCraft CMSMonicaPagerDutyQualtricsBoomiLinkedIn Sales NavigatorDenodo.

What is GRAIL's email format?

GRAIL's email format typically follows the pattern of FLast@grail.com. Find more GRAIL email formats with LeadIQ.

How much funding has GRAIL raised to date?

As of October 2025, GRAIL has raised $5.7B in funding. The last funding round occurred on May 06, 2020 for $390M.

When was GRAIL founded?

GRAIL was founded in 2016.

GRAIL

GRAIL

Biotechnology ResearchCalifornia, United States1001-5000 Employees

Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care.

We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges.

GRAIL is headquartered in Menlo Park, California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies. 

For more information, please visit grail.com.

Community Guidelines: https://bit.ly/3xigb24

Company Overview

Headquarters: 1525 O'Brien Drive Menlo Park, CA 94025 US
Phone number: +1-650-454-****
Website: grail.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: GRAL
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2016
Employees: 1001-5000

Media & News

Funding & Financials

$5.7B
GRAIL has raised a total of $5.7B of funding over 6 rounds. Their latest funding round was raised on May 06, 2020 in the amount of $390Mas a Series D.
$50M$100M
GRAIL's revenue is estimated to be in the range of $50M$100M

Funding & Financials

$5.7B
GRAIL has raised a total of $5.7B of funding over 6 rounds. Their latest funding round was raised on May 06, 2020 in the amount of $390Mas a Series D.
$50M$100M
GRAIL's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.